Alan L. Chang

Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors

Derek A. Wainwright, Alan L. Chang, Mahua Dey et al. · Clinical Cancer Research · 2014 · 578 citations · Full text

Life Sciences, Immunology, Oncology +17

IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival

Derek A. Wainwright, Irina V. Balyasnikova, Alan L. Chang et al. · Clinical Cancer Research · 2012 · 466 citations · Full text

Medicine, Immunology, Oncology +17

HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma

Jason Miska, Catalina Lee-Chang, Aida Rashidi et al. · Cell Reports · 2019 · 312 citations · Full text

Medicine, Immunology, Oncology +17

Clinical validation of the tempus xT next-generation targeted oncology sequencing assay

Nike Beaubier, Robert Tell, Denise Lau et al. · Oncotarget · 2019 · 241 citations · Full text

Life Sciences, Genetics, Oncology +17

Phosphodiesterase A1, a Regulator of Cellulose Synthesis in <i>Acetobacter xylinum</i>, Is a Heme-Based Sensor

Alan L. Chang, Jason R. Tuckerman, G. González et al. · Biochemistry · 2001 · 223 citations

Life Sciences, Biochemistry, Microbiology +14